Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies

aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies

US Patent 6207160 · Granted Mar 27, 2001

Estimated economic value: $4,678,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA2024
Anti-IL-6 antibody2024
Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA2021
Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody2021
Relating to ultrasonic cleaning2019
Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA2018
Ultrasonic cleaning apparatus and method2018
Methods of treating a fatty acid amide hydrolase-mediated condition2018
Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA2017
Pen-injector device containing anti-IL-6 antibodies2017
Anti-IL-6 antibodies, compositions, methods and uses2016
Methods for stereoselective reduction2016